Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Apr 2, 2026
Purchase
Shares
713,800
Price
$2.10
Total Value
$1.50M
Shares Held After
3,288,539
% of Holdings
21.7%

Lipocine Inc. (LPCN)

Patel Mahesh V. — Director
Apr 2, 2026
Purchase
Shares
25,000
Price
$2.02
Total Value
$50.50K
Shares Held After
135,679
% of Holdings
18.4%

Neuraxis, INC (NRXS)

Henrichs Timothy Robert — Chief Financial Officer
Apr 1, 2026
Purchase
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%

Neuraxis, INC (NRXS)

Carrico Thomas Joeseph — CRO, CCO, CPO
Apr 1, 2026
Purchase
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Apr 1, 2026
Purchase
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Apr 1, 2026
Purchase
Shares
15,000
Price
$3.14
Total Value
$47.10K
Shares Held After
47,500
% of Holdings
31.6%

Altimmune, Inc. (ALT)

WEAVER GREGORY L — Chief Financial Officer
Apr 1, 2026
Purchase
Shares
10,000
Price
$3.15
Total Value
$31.50K
Shares Held After
38,078
% of Holdings
26.3%
Mar 31, 2026
Purchase
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%

Zenas BioPharma, Inc. (ZBIO)

Lu Hongbo — Director
Mar 31, 2026
Purchase
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
Mar 31, 2026
Purchase
Shares
520
Price
$10.60
Total Value
$5.51K
Shares Held After
1,538,296
% of Holdings
0.0%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy — Chief Administrative Officer
Mar 31, 2026
Purchase
Shares
1,854
Price
$2.54
Total Value
$4.70K
Shares Held After
3,110
% of Holdings
59.6%
Mar 31, 2026
Purchase
Shares
2,136
Price
$2.54
Total Value
$5.41K
Shares Held After
3,649
% of Holdings
58.5%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick — Chief Business - Strategy Off
Mar 31, 2026
Purchase
Shares
1,603
Price
$2.54
Total Value
$4.06K
Shares Held After
3,356
% of Holdings
47.8%
Mar 31, 2026
Purchase
Shares
1,810
Price
$2.54
Total Value
$4.59K
Shares Held After
10,562
% of Holdings
17.1%
Mar 31, 2026
Purchase
Shares
2,072
Price
$2.54
Total Value
$5.25K
Shares Held After
2,188
% of Holdings
94.7%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Mar 31, 2026
Purchase
Shares
2,324
Price
$2.54
Total Value
$5.89K
Shares Held After
2,324
% of Holdings
100.0%
Mar 31, 2026
Purchase
Shares
2,269
Price
$2.54
Total Value
$5.75K
Shares Held After
2,325
% of Holdings
97.6%

Processa Pharmaceuticals, Inc. (PCSA)

Bigora Sian — Chief Development Officer
Mar 31, 2026
Purchase
Shares
2,107
Price
$2.54
Total Value
$5.34K
Shares Held After
3,711
% of Holdings
56.8%
Mar 31, 2026
Purchase
Shares
1,160,000
Price
$3.45
Total Value
$4.00M
Shares Held After
13,160,000
% of Holdings
8.8%
Mar 31, 2026
Purchase
Shares
150,000
Price
$20.00
Total Value
$3.00M
Shares Held After
2,359,025
% of Holdings
6.4%
Mar 31, 2026
Purchase
Shares
5,000
Price
$12.62
Total Value
$63.10K
Shares Held After
20,001
% of Holdings
25.0%

CURIS INC (CRIS)

KAITIN KENNETH I — Director
Mar 31, 2026
Purchase
Shares
10,000
Price
$0.55
Total Value
$5.49K
Shares Held After
11,407
% of Holdings
87.7%
Mar 31, 2026
Purchase
Shares
15,000
Price
$2.04
Total Value
$30.60K
Shares Held After
21,246
% of Holdings
70.6%
Mar 31, 2026
Purchase
Shares
34,000
Price
$19.31
Total Value
$656.54K
Shares Held After
1,726,039
% of Holdings
2.0%

Zenas BioPharma, Inc. (ZBIO)

Lu Hongbo — Director
Mar 31, 2026
Purchase
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%
Mar 30, 2026
Purchase
Shares
2,000
Price
$17.08
Total Value
$34.16K
Shares Held After
15,500
% of Holdings
12.9%
Mar 30, 2026
Purchase
Shares
445
Price
$112.30
Total Value
$49.97K
Shares Held After
187,616
% of Holdings
0.2%
Mar 30, 2026
Purchase
Shares
20,000
Price
$18.23
Total Value
$364.60K
Shares Held After
1,692,039
% of Holdings
1.2%
Mar 30, 2026
Purchase
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%
Mar 30, 2026
Purchase
Shares
58,300
Price
$24.16
Total Value
$1.41M
Shares Held After
5,825,521
% of Holdings
1.0%
Mar 30, 2026
Purchase
Shares
971,091
Price
$6.50
Total Value
$6.31M
Shares Held After
26,975,505
% of Holdings
3.6%
Version: v26.3.33